Discovering new drugs requires tremendous investment and the ability to face difficult odds, but advances in computing and data science can expedite the process and reduce time-to-market. In silico research and data-driven insights promise to both deliver new therapeutic targets faster and also re-purpose existing drugs. Combining the right approach to capturing, storing, and analyzing data with high-performance computing can make all the difference in delivering significant time and cost-savings for drug discovery programs.

Click here to download the full solution brief